ProUroCare Medical

ProUroCare Medical Free Cash Flow

The Free Cash Flow (FCF) of ProUroCare Medical (PUMD) as of Nov 2, 2026 is -1.13 M USD.

Free Cash Flow

-1.13 MUSD

Last updated:

Free Cash Flow (FCF) of ProUroCare Medical is 2012 -1.13 M USD. Free Cash Flow (FCF) of ProUroCare Medical was 2011 - USD. It decreases by % lower compared to the previous year.

The ProUroCare Medical Free Cash Flow history

The ProUroCare Medical Free Cash Flow history
YEARFree Cash FlowYoY
-1.13 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ProUroCare Medical Stock analysis

What does ProUroCare Medical do? ProUroCare Medical Inc develops the ProUroScan System, a prostate mechanical imaging device for detecting and characterizing male prostate disease. The system uses sensors on a rectal probe, a central processing unit, and software to generate real-time color images of prostate abnormalities detected via digital rectal examination. It provides elasticity imaging, offering non-invasive tissue analysis, and delivers two- and three-dimensional prostate images. The company sells this medical device directly to healthcare providers for diagnostic use. The ProUroScan System is marketed as an adjunctive aid for visualizing prostate abnormalities identified during digital rectal exams. Healthcare providers, including urologists and specialists in prostate health, purchase the device to enhance diagnostic capabilities. The product targets medical facilities requiring advanced imaging solutions for prostate disease detection and characterization. ProUroCare focuses exclusively on the ProUroScan System, with no other products mentioned in the business description. The company’s revenue comes solely from the sale of this imaging system to healthcare professionals and institutions. The device is positioned as a tool for improving diagnostic accuracy in prostate examinations. ProUroCare Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ProUroCare Medical stock

Free Cash Flow (FCF) of ProUroCare Medical is -1.13 M USD in 2012.

On Eulerpool you can find the complete historical development of Free Cash Flow (FCF) ProUroCare Medical since 2006 – with annual values, charts, and detailed analysis.

Free Cash Flow is the cash available after capital expenditures. It represents the cash a company can use for dividends, debt reduction, or reinvestment.

FCF = Operating Cash Flow - Capital Expenditures

Free Cash Flow (FCF)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Free Cash Flow (FCF)'s ProUroCare Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ProUroCare Medical

All Key Metrics — ProUroCare Medical